Biography

Dr. Sharareh Senemar is a Postdoctoral Associate in the Department of Pharmaceutics at the University of Long Island University, Brooklyn, NY. She obtained Pharm.D degree in Pharmacy at Kerman University of Medical Sciences, Iran, and a Master of Science in Industrial Pharmacy at Long Island University, Brooklyn, NY. She earned a Ph.D. in Pharmaceutics and Drug Design at Long Island University, Brooklyn, NY. She has been awarded 2021 and 2019 AAPS Best Abstracts and nominated for AAPS Best Poster awards in 2019 and 2021. She was awarded 1st place for poster presentation at the Centre for Dermal Research 2019 conference. She received the 2019 1st AAPS Student Board Chapter Award. She is a member of the Learning Opportunities Management Team, AAPS Topical Transdermal Community since 2019, conducting monthly webinars related to topical transdermal drug developments. Member of The Rho Chi Society-Beta Theta Chapter. Member of Microdialysis Focus Group “Probes” contributor. Member of American Society of Iranian Pharmaceutical Scientists (ASIPS). She is the lead Research on an FDA grant titled "Elucidating Fundamental Principles of Dermal Pharmacokinetics via Microdialysis" to investigate the profound science of skin pharmacokinetics at Long Island University, Brooklyn, NY. She Collaborated with FDA through provided grant “Benchmark of Dermis Microdialysis to assess Bioequivalence of Dermatological Topical Products”, to investigate bioavailability and bioequivalence of topical dermatological products by microdialysis through numerous preclinical studies.


Research Interest

Dr. Sharareh Senemar is interested in fields of research that are pharmacokinetics and pharmacodynamics. Her current research focuses on assessing dermal disposition via a novel technique “dermal infusion”, developed in her lab. She investigates the dermal bioavailability and bioequivalence of topical dermatological drug products. Her research supports the application of basic pharmacokinetics principles in the assessment of bioavailability and/or bioequivalence of topical products in animals and humans using the DMD technique.